Denali Therapeutics
DNLI
#4222
Rank
โ‚น231.60 B
Marketcap
โ‚น1,579
Share price
-10.63%
Change (1 day)
-24.03%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -โ‚น251.60

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น261.54. In 2024 the company made an earnings per share (EPS) of -โ‚น230.99 a decrease over its 2023 EPS that were of -โ‚น93.47.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น251.608.92%
2024-โ‚น230.99147.12%
2023-โ‚น93.47-60%
2022-โ‚น233.688.79%
2021-โ‚น214.81-712.82%
2020โ‚น35.05-118.93%
2019-โ‚น185.15402.44%
2018-โ‚น36.85-88.89%
2017-โ‚น331.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novocure
NVCR
-โ‚น144.70-44.67% Jersey
Novavax
NVAX
โ‚น190.54-172.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
-โ‚น1,035 295.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น638.13 143.99%๐Ÿ‡ฌ๐Ÿ‡ง UK